Apoptosis analysis demonstrated that treating myeloma cells with PD‐L1 antibodies after chemotherapy significantly enhances the cytotoxic efficiency of activated T cells compared to the reverse sequence (Figure 7B). Here, CD274 is linked to plasma cell myeloma.